GAS5 is mainly identified as a well-characterized tumor suppressor, and is downregulated in a wide range of human malignancies, including lung cancer, renal cell carcinoma, breast cancer, and bladder cancer, indicating that GAS5 could be utilized as a potential diagnostic hallmark [6,8]. Here, GAS5 is linked to renal cell carcinoma.